Alpha Cancer Technologies (aka ACT)

A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Alpha Cancer Technologies (aka ACT) plus 5768 other startups.

Get A Demo

Learn More About Alpha Cancer Technologies (aka ACT)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Companies We Work With